Group One Trading, L.P. Bristol Myers Squibb CO Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1.67 Million - $2.2 Million	41,476 Added 46.44%	130,790 $5.43 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $3.05 Million - $3.46 Million	63,638 Added 247.85%	89,314 $4.84 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $1.1 Million - $1.31 Million	-22,723 Reduced 46.95%	25,676 $1.32 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $2.8 Million - $3.13 Million	48,399 New	48,399 $2.81 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $5.52 Million - $6.54 Million	80,602 Added 173.6%	127,033 $9.14 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $6,036 - $3.57 Million	46,431 New	46,431 $3.3 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $14.1 Million - $16.9 Million	-228,990 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $679,063 - $791,628	-12,662 Reduced 5.24%	228,990 $14.3 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $2.23 Million - $2.62 Million	-37,751 Reduced 13.51%	241,652 $14.3 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $2.61 Million - $2.85 Million	42,237 Added 17.81%	279,403 $18.7 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $3.22 Million - $3.63 Million	-54,342 Reduced 18.64%	237,166 $15 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $10.4 Million - $11.7 Million	179,460 Added 160.16%	291,508 $18.1 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $308,284 - $341,619	5,368 Added 5.03%	112,048 $6.76 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $848,394 - $991,856	15,476 Added 16.97%	106,680 $6.27 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $4.23 Million - $6.15 Million	91,204 New	91,204 $5.08 Million
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $791,739 - $1.03 Million	-16,089 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $688,126 - $815,873	16,089 New	16,089 $816,000
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $4.71 Million - $5.21 Million	-105,621 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $6.14 Million - $7.32 Million	-135,975 Reduced 56.28%	105,621 $5.04 Million
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $10.9 Million - $14.1 Million	223,405 Added 1228.11%	241,596 $12.6 Million
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $7.99 Million - $9.02 Million	-144,842 Reduced 88.84%	18,191 $1.13 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $5.48 Million - $6.83 Million	108,503 Added 198.98%	163,033 $9.02 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $7.69 Million - $8.86 Million	-128,416 Reduced 70.19%	54,530 $3.45 Million
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $2.9 Million - $3.17 Million	-48,448 Reduced 20.94%	182,946 $11.2 Million
Q3 2017 Nov 15, 2017	SELL	$55.23 - $63.74 $5.67 Million - $6.55 Million	-102,718 Reduced 30.74%	231,394 $14.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	334,112	334,112 $18.6 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account